NCT01900340View on ClinicalTrials.gov

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Appetite and General Nutritional Disorders
Interventions
DIETARY_SUPPLEMENT

Saline

Intravenous saline infusion and intraduodenal administration of saline via feeding tube

DRUG

Exendin 9-39

IV exendin(9-39) infusion and intraduodenal administration of saline via feeding tube

DIETARY_SUPPLEMENT

Saline

IV saline infusion and intraduodenal administration of nutrients

DRUG

Exendin(9-39) plus ID nutrient

Exendin(9-39) as intravenous infusion plus intraduodenal nutrient administration

Trial Locations (1)

Unknown

University Hospital Basel, Phase 1 Research Unit, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT01900340 - Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans | Biotech Hunter | Biotech Hunter